Drug Interaction Report

Relacorilant and Simvastatin: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 4, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Relacorilant

Lifyorli
+

Simvastatin

Flolipid Flolipid® Zocor Zocor®
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 4, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 139 documented Relacorilant interactions, 139 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be stronger
The Bottom Line
Relacorilant can raise simvastatin levels and the risk of muscle side effects, so this combination is generally avoided unless your care team specifically recommends it. Keep taking both as prescribed and check with your pharmacist or doctor about the safest plan.

Here's what's going on. Simvastatin (Zocor) is a cholesterol medicine that your body breaks down using a liver enzyme called CYP3A4. Relacorilant (Lifyorli) can slow that enzyme down. When the enzyme is slowed, simvastatin can build up in your body to higher levels than intended.

With statins, higher levels can mean a bigger chance of muscle aches or, rarely, more serious muscle problems. The good news is that this is very manageable. Your care team knows about this combination and can watch you closely, adjust things, or choose a different option if needed. Please don't stop either medicine on your own, just check in with your pharmacist or doctor.

Mechanism: Relacorilant inhibits CYP3A4, the primary enzyme metabolizing simvastatin (a CYP3A4 substrate). Neither drug is a prodrug here, so inhibition raises simvastatin exposure.

  • Direction: Increased simvastatin AUC/Cmax and increased risk of statin-related adverse effects (myopathy, rhabdomyolysis).
  • Severity/evidence: Major; substantiation probable.
  • Onset: Unspecified.
  • Management: Manufacturer guidance is to avoid concomitant use unless otherwise recommended. If co-administered, individualize dosing and monitor for muscle pain, weakness, and CK; consider a statin less dependent on CYP3A4 as an alternative per the care team.
Onset
unspecified
Evidence
probable
Severity
Major

What happens

Increased CYP3A4 substrate exposure and an increased risk of CYP3A4-substrate-related adverse reactions

Interaction Deep Dive

Unless there is a specific recommendation to do otherwise, the combined use of relacorilant with CYP3A4 substrates should be avoided. Using them together may raise the exposure to these substrates and heighten the likelihood of adverse reactions associated with them1.

Why it happens (mechanism)

Inhibition of CYP3A4-mediated metabolism of relacorilant

How to manage this interaction

What your care team may do:

  • Because relacorilant can raise simvastatin levels, the labeling recommends avoiding this combination unless your team decides it's needed.
  • If both are used, your team may adjust the simvastatin dose, monitor you more closely for muscle symptoms, or consider a different cholesterol medicine.

What you should do:

  • Keep taking both exactly as prescribed until your care team tells you otherwise.
  • Report any muscle pain, tenderness, weakness, or dark urine promptly.
  • Ask your pharmacist or prescriber whether this combination is right for you or if an alternative fits better.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

1 report — tap to read

a) In studies evaluating drug interactions, giving relacorilant 350 mg in the fasted state (equivalent to 1.8 times the relacorilant exposure achieved at the recommended dose) once daily over 10 days together with midazolam (a CYP3A4 substrate) raised the Cmax by 3.1-fold and the AUC by 8.9-fold 1.

Common questions

Can I take Relacorilant and Simvastatin together?

Relacorilant can raise simvastatin levels and the risk of muscle side effects, so this combination is generally avoided unless your care team specifically recommends it. Keep taking both as prescribed and check with your pharmacist or doctor about the safest plan. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Relacorilant and Simvastatin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Relacorilant and Simvastatin interaction managed?

What your care team may do: Because relacorilant can raise simvastatin levels, the labeling recommends avoiding this combination unless your team decides it's needed. If both are used, your team may adjust the simvastatin dose, monitor you more closely for muscle symptoms, or consider a different cholesterol medicine. What you should do: Keep taking both exactly as prescribed until your care team… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

From our Q&A

Real reader questions about these medications, each personally answered by our pharmacist:

Questions for your pharmacist

  • Does my dose of Relacorilant or Simvastatin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: LIFYORLI™ oral capsules, relacorilant oral capsules. Corcept Therapeutics Incorporated (Per Manufacturer), Redwood City, CA, 2026. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.